Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Jul 27, 2025; 17(7): 101767
Published online Jul 27, 2025. doi: 10.4240/wjgs.v17.i7.101767
Published online Jul 27, 2025. doi: 10.4240/wjgs.v17.i7.101767
Table 2 Summary of healing and failure rates for the top five most frequently reported intervention categories
Frequency of healing or failure category, range (number of articles) | ||||
‘Healing’ | ‘Failure’ | |||
Category | Fistula healing/closure | Partial response | Active disease after treatment | Recurrence |
Biologics | 8.8%-78.4% (n = 17) | 11.9%-68.3% (n = 7) | 10.7%-55.6% (n = 10) | 7.9%-45.0% (n = 5) |
Loose seton | 17.7%-60.5% (n = 5) | 25.0% (n = 1) | 41.7%-51.0% (n = 2) | 4.0%-68.0% (n = 5) |
Surgery (other than seton) | 40.7%-75.0% (n = 6) | 15.5%-41.6% (n = 3) | 22.5%-42.0% (n = 3) | 39.5%-64.0% (n = 3) |
Immunosuppressants | 25.0%-54.8% (n = 3) | 19.1% (n = 1) | 9.5% (n = 1) | 28.6%-46.9% (n = 3) |
Fistulectomy/-otomy | 47.9%-90.3% (n = 4) | Not reported | 3.4% (n = 1) | 17.9% (n = 1) |
- Citation: McKay C, Bolzani A, Kienzle S, Geransar P, Panés J. Epidemiology, treatment patterns, and associated risk factors in perianal fistulizing Crohn’s disease: A systematic literature review. World J Gastrointest Surg 2025; 17(7): 101767
- URL: https://www.wjgnet.com/1948-9366/full/v17/i7/101767.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i7.101767